Expert perspectives on clinical trial technology, ePRO, eSource, and the evolving CEE research landscape.
Electronic Patient Reported Outcomes are reshaping how clinical trial data is captured at the source. For Central and Eastern Europe, the adoption gap is both a challenge and an opportunity.
Every manual transcription step introduces delay and error. eSource eliminates both. Here is what the data says about the operational cost of staying on paper.
Enterprise platforms are built for global pharma portfolios. But most CEE trials need focused capability, not maximum configurability. The architectural difference between a 12-month deployment and a 4-week deployment is modularity.